Home Avalanche Biotechnologies: Unsustainable Price Presents Attractive Short Opportunity
 

Keywords :   


Avalanche Biotechnologies: Unsustainable Price Presents Attractive Short Opportunity

2014-12-16 12:35:54| Biotech - Topix.net

When compared to its closest peer, the company appears to be significantly overvalued, and at more reasonable multiples Avalanche could see 50% downside. The stock has outrun its fundamentals, its story, and even optimistic analyst price targets, which positions it well for a short opportunity.

Tags: price short opportunity presents

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Boeing makes 38% pay rise offer in bid to end strike
01.11The house paints that promise much more than colour
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11How Japan's youngest CEO transformed Hello Kitty
31.10Unicharm to Expand in Africa
More »